During the past decade, Hospital Alemao Oswaldo Cruz conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 18 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 14 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Alemao Oswaldo Cruz" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Hospital Alemão Oswaldo Cruz" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Alemao Oswaldo Cruz" #1 collaborator was "CytoDyn, Inc." with 2 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Alemao Oswaldo Cruz" are "COVID-19" (6 trials), "COVID-19 Pneumonia" (3 trials), "Coronavirus" (3 trials), "Arthritis, Rheumatoid" (2 trials) and "COVID" (2 trials). Many other conditions were trialed in "Hospital Alemao Oswaldo Cruz" in a lesser frequency.

Most popular intervention types in "Hospital Alemao Oswaldo Cruz" are "Drug" (48 trials), "Other" (10 trials), "Biological" (5 trials), "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Atezolizumab" (4 trials), "Amivantamab" (2 trials), "Baricitinib" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Alemao Oswaldo Cruz" are 53 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Alemao Oswaldo Cruz". 1 are not yet recruiting, 16 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Hospital Alemao Oswaldo Cruz, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Alemao Oswaldo Cruz, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".